Mr. James Howard-Tripp reports
GENENEWS CLOSES FUNDING FOR SECOND CONVERTIBLE SECURITY FUNDING AGREEMENT WITH LIND ASSET MANAGEMENT
GeneNews Ltd. has closed the financing amount of $500,000 under the previously announced convertible security financing agreement with Lind Asset Management XI LLC.
As disclosed on Dec. 28, 2018, under the terms of the agreement, the company has issued the convertible security and warrants.
The agreement and the issuance of securities thereunder have been conditionally approved by the Toronto Stock Exchange and are subject to satisfaction of customary closing conditions.
About GeneNews Ltd.
GeneNews, an innovator in the liquid biopsy space, is committed to becoming a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. The company's mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health outcomes through the early diagnosis of disease.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.